Tumour Necrosis Factor (TNF) Gene Polymorphism Influences TNF-alpha Production in Lipopolysaccharide (LPS)-stimulated Whole Blood Cell Culture in Healthy Humans

Overview

Journal Clin Exp Immunol

Publisher Oxford University Press

Specialty Allergy & Immunology

Date 1998 Sep 16

PMID 9737669

Citations 128

Authors

E Louis

D Franchimont

A Piron

Y Gevaert

N Schaaf-Lafontaine

S Roland

P Mahieu

M Malaise

D De Groote

R Louis

J Belaiche

Affiliations

Soon will be listed here.

Abstract

TNF-alpha is involved in infectious and immuno-inflammatory diseases. Different individuals may have different capacities for TNF-alpha production. This might determine a predisposition to develop some complications or phenotypes of these diseases. The aims of our study were to assess the inter-individual variability of TNF-alpha production and to correlate this variability to a single base pair polymorphism located at position -308 in TNF gene. We studied 62 healthy individuals. TNF-alpha production after LPS stimulation was evaluated using a whole blood cell culture model. The TNF gene polymorphism was studied by an allele-specific polymerase chain reaction. Other cytokines produced in the culture, soluble CD14 concentrations and expression of CD14 on blood cells were also measured. Among the 62 individuals, 57 were successfully genotyped. There were 41 TNF1 homozygotes and 16 TNF1/TNF2 heterozygotes. TNF-alpha production after LPS stimulation of whole blood cell culture was higher among TNF2 carriers than among TNFI homozygotes (929pg/ml (480-1473pg/ml) versus 521 pg/ ml (178-1307 pg/ml); P<0.05). This difference was even more significant after correction of TNF-alpha production for CD14 expression on blood cells. In conclusion, the single base pair polymorphism at position -308 in the TNF gene may influence TNF-alpha production in healthy individuals.

Citing Articles

Candidate gene polymorphisms associated with silicosis and coal workers' pneumoconiosis: a systematic review and meta-analysis.

Zhang Y, Sun D, Song Y, Ye Q BMC Pulm Med. 2024; 24(1):580.

PMID: 39578762 PMC: 11585218. DOI: 10.1186/s12890-024-03392-0.

Diversity, Complexity, and Specificity of Bacterial Lipopolysaccharide (LPS) Structures Impacting Their Detection and Quantification.

Dardelle F, Phelip C, Darabi M, Kondakova T, Warnet X, Combret E Int J Mol Sci. 2024; 25(7).

PMID: 38612737 PMC: 11011966. DOI: 10.3390/ijms25073927.

Association of tumor necrosis factor-α-308G/A polymorphism with the risk of obstructive sleep apnea: A meta-analysis of 14 case-control studies.

Zhang Z, Duolikun D, Dang T, Wang Y, Ma L, Ma X PLoS One. 2023; 18(8):e0290239.

PMID: 37595008 PMC: 10437904. DOI: 10.1371/journal.pone.0290239.

Demographic, clinical and genetic factors associated with COVID-19 disease susceptibility and mortality in a Kurdish population.

Smail S, Babaei E, Amin K Ann Saudi Med. 2023; 43(3):125-142.

PMID: 37270678 PMC: 10317494. DOI: 10.5144/0256-4947.2023.125.

Polymorphisms within the Tumor Necrosis Factor-Alpha Gene Is Associated with Preeclampsia in Taiwanese Han Populations.

Lin C, Chen C, Wu M, Chang F, Kang L Biomedicines. 2023; 11(3).

PMID: 36979841 PMC: 10045416. DOI: 10.3390/biomedicines11030862.

References

Beutler B, Milsark I, Cerami A . Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science. 1985; 229(4716):869-71. DOI: 10.1126/science.3895437. View

Goyert S, Ferrero E, Seremetis S, Winchester R, Silver J, Mattison A . Biochemistry and expression of myelomonocytic antigens. J Immunol. 1986; 137(12):3909-14. View

Tracey K, Fong Y, Hesse D, Manogue K, Lee A, Kuo G . Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature. 1987; 330(6149):662-4. DOI: 10.1038/330662a0. View

Passlick B, Flieger D . Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood. 1989; 74(7):2527-34. View

Jacob C, Fronek Z, Lewis G, Koo M, Hansen J, McDevitt H . Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci U S A. 1990; 87(3):1233-7. PMC: 53445. DOI: 10.1073/pnas.87.3.1233. View

Arditi M, Manogue K, Caplan M, Yogev R . Cerebrospinal fluid cachectin/tumor necrosis factor-alpha and platelet-activating factor concentrations and severity of bacterial meningitis in children. J Infect Dis. 1990; 162(1):139-47. DOI: 10.1093/infdis/162.1.139. View

Lauener R, Goyert S, Geha R, Vercelli D . Interleukin 4 down-regulates the expression of CD14 in normal human monocytes. Eur J Immunol. 1990; 20(11):2375-81. DOI: 10.1002/eji.1830201103. View

Nedospasov S, Udalova I, Kuprash D, Turetskaya R . DNA sequence polymorphism at the human tumor necrosis factor (TNF) locus. Numerous TNF/lymphotoxin alleles tagged by two closely linked microsatellites in the upstream region of the lymphotoxin (TNF-beta) gene. J Immunol. 1991; 147(3):1053-9. View

Bazil V, Strominger J . Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes. J Immunol. 1991; 147(5):1567-74. View

10.

Glauser M, Zanetti G, Baumgartner J, Cohen J . Septic shock: pathogenesis. Lancet. 1991; 338(8769):732-6. DOI: 10.1016/0140-6736(91)91452-z. View

11.

de Waal Malefyt R, Abrams J, Bennett B, Figdor C, De Vries J . Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med. 1991; 174(5):1209-20. PMC: 2119001. DOI: 10.1084/jem.174.5.1209. View

12.

Strobel M, Kieper D, FINGERLE G, Schlunck T, Petersmann I, Ellwart J . Differential expression of cytokines in human blood monocyte subpopulations. Blood. 1992; 79(2):503-11. View

13.

Schutt C, Schilling T, Grunwald U, SCHONFELD W, Kruger C . Endotoxin-neutralizing capacity of soluble CD14. Res Immunol. 1992; 143(1):71-8. DOI: 10.1016/0923-2494(92)80082-v. View

14.

De Groote D, Zangerle P, Gevaert Y, Fassotte M, Beguin Y, Noizat-Pirenne F . Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine. 1992; 4(3):239-48. DOI: 10.1016/1043-4666(92)90062-v. View

15.

Martin T, Mathison J, Tobias P, Leturcq D, Moriarty A, Maunder R . Lipopolysaccharide binding protein enhances the responsiveness of alveolar macrophages to bacterial lipopolysaccharide. Implications for cytokine production in normal and injured lungs. J Clin Invest. 1992; 90(6):2209-19. PMC: 443371. DOI: 10.1172/JCI116106. View

16.

Pociot F, Briant L, Jongeneel C, Molvig J, Worsaae H, Abbal M . Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol. 1993; 23(1):224-31. DOI: 10.1002/eji.1830230135. View

17.

Wilson A, de Vries N, Pociot F, Di Giovine F, van der Putte L, Duff G . An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med. 1993; 177(2):557-60. PMC: 2190902. DOI: 10.1084/jem.177.2.557. View

18.

Ulevitch R . CD14: cell surface receptor and differentiation marker. Immunol Today. 1993; 14(3):121-5. DOI: 10.1016/0167-5699(93)90212-4. View

19.

De Groote D, Gevaert Y, Lopez M, Gathy R, Fauchet F, Dehart I . Novel method for the measurement of cytokine production by a one-stage procedure. J Immunol Methods. 1993; 163(2):259-67. DOI: 10.1016/0022-1759(93)90130-y. View

20.

Reinecker H, Steffen M, Witthoeft T, Pflueger I, Schreiber S, Macdermott R . Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol. 1993; 94(1):174-81. PMC: 1534387. DOI: 10.1111/j.1365-2249.1993.tb05997.x. View